The pharmacokinetics of cefmetazole were investigated in 7 elderly patients (4 males, 3 females) and in 5 healthy volunteers (males). The drug was given in travenously at 10 mg/kg. The creatinine, clearance values of the elderly patients and healthy volunteers were 53.6 to 64.5 ml/min and 93.7 ml/min, respectively. The concentrations of cefmetazole in the serum and urine were determined by bioassay, and pharmacokinetic parameters were calculated on the basis of a two-compartment open model. The cumulative urinary excretion of cefmetazole at 8 hr after its injection was about 90% of the total dose in healthy volunteers, and about 60% of the dose in elderly patients. A negative correlation between age and the elimination rate constant observed.
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From these results, it was suggested that the decreased renal function re duced urinary excretion of cefmetazole in elderly patients, while the increased volume of distribution of cefmetazole, in particular, in bedridden elderly patients may be caused by age. generally accepted that renal function, especially creatinine clearance, decreases in elderly pa tients, and when cefmetazole is used for these patients, renal function should be considered in determining the dosage schedule because this drug is excreted mainly unchanged in the urine.
In this study, we compared the pharmacokine tics of cefmetazole in elderly patients and healthy seems that the increase of Vd in bedridden elderly patients may be related to decrease in the serum albumin level and also to reduced cardiac output14) and slower peripheral circulation15) and to increased extracellular fluid; however, which of the factors may be related to the increase of Vd in these patients could not be determined in the present study. In addition to these factors, the differences in physical activity, age and sex between these bedridden and ambulatory elderly patients may be related to the increase of Vd in bedridden elderly patients.
From these results, the decreased urinary ex cretion of cefmetazole in elderly patients is concluded to be affected by the decrease in renal function with age, and we are now investigating which factors may effect the increase of Vd in elderly patients. In any case, it is clear that when cefmetazole is given to elderly patients, especial ly bedridden elderly patients, increased t1/2 and Vdss must be considered in determining a suitable dose that does not cause intoxication.
